Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1

被引：3

作者：

Wannigama, Dhammika Leshan ^{[1
,2
,3
,4
,6
,7
,8
]}

Amarasiri, Mohan ^{[2
,9
]}

Phattharapornjaroen, Phatthranit ^{[2
,10
,11
]}

Hurst, Cameron ^{[2
,12
]}

Modchang, Charin ^{[13
,14
,15
]}

Chadsuthi, Sudarat ^{[16
]}

Anupong, Suparinthon ^{[1
,13
]}

Miyanaga, Kazuhiko ^{[17
]}

Cui, Longzhu ^{[17
]}

Fernandez, Stefan ^{[18
]}

Huang, Angkana ^{[19
]}

Ounjai, Puey ^{[20
]}

Singer, Andrew C. ^{[21
]}

Ragupathi, Naveen Kumar Devanga ^{[4
,22
]}

Sano, Daisuke ^{[23
,24
]}

Furukawa, Takashi

Sei, Kazunari ^{[8
]}

Leelahavanichkul, Asada ^{[2
,25
]}

Kanjanabuch, Talerngsak ^{[5
,26
,27
,28
]}

Chatsuwan, Tanittha ^{[4
,8
]}

Higgins, Paul G. ^{[2
,29
,30
,31
]}

Nanbo, Asuka ^{[32
]}

Kicic, Anthony

Siow, Richard ^{[37
,38
,39
]}

Trowsdale, Sam ^{[40
]}

Hongsing, Parichart ^{[41
]}

Khatib, Aisha ^{[33
,34
,35
,36
,42
]}

Shibuya, Kenji ^{[43
]}

Abe, Shuichi ^{[2
]}

Ishikawa, Hitoshi ^{[2
,8
]}

机构：

[1] Yamagata Prefectural Cent Hosp, Dept Infect Dis & Infect Control, Yamagata 9902292, Japan

[2] Yamagata Prefectural Cent Hosp, Dept Infect Dis & Infect Control, Pathogen Hunters Res Collaborat Team, Yamagata, Japan

[3] Yamagata Prefectural Univ Hlth Sci, Yamagata, Japan

[4] Chulalongkorn Univ, Fac Med, Ctr Excellence Antimicrobial Resistance & Stewards, Bangkok, Thailand

[5] Chulalongkorn Univ, Ctr Excellence Kidney Metab Disorders, Fac Med, Bangkok, Thailand

[6] Univ Western Australia, Fac Hlth & Med Sci, Sch Med, Perth, WA, Australia

[7] Univ Sheffield, Biofilms & Antimicrobial Resistance Consortium ODA, Sheffield, England

[8] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Microbiol,Fac Med, Bangkok, Thailand

[9] Kitasato Univ, Sch Allied Hlth Sci, Grad Sch Med Sci, Dept Hlth Sci,Lab Environm Hyg, Tokyo, Japan

[10] Mahidol Univ, Fac Med, Ramathibodi Hosp, Bangkok, Thailand

[11] Gothenburg Univ, Dept Surg, Inst Clin Sci, Sahlgrenska Acad, Gothenburg, Sweden

[12] Charles Darwin Univ, Molly Wardaguga Res Ctr, Brisbane, Qld, Australia

[13] Mahidol Univ, Fac Sci, Dept Phys, Biophys Grp, Bangkok, Thailand

[14] Minist Higher Educ Sci Res & Innovat, Ctr Excellence Phys, Bangkok, Thailand

[15] Minist Higher Educ, Ctr Excellence Math Sci Res & Innovat, Bangkok, Thailand

[16] Naresuan Univ, Fac Sci, Dept Phys, Phitsanulok, Thailand

[17] Jichi Med Univ, Div Bacteriol, Sch Med, Shimotsuke, Tochigi, Japan

[18] Armed Forces Res Inst Med Sci, Dept Virol, US Army Med Directorate, Bangkok, Thailand

[19] Univ Cambridge, Dept Psychol, Cambridge, England

[20] Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand

[21] UK Ctr Ecol & Hydrol, Wallingford, England

[22] Bioberrys Healthcare & Res Ctr, Dept Res & Dev, Div Microbial Interact, Vellore, India

[23] Tohoku Univ, Grad Sch Environm Studies, Dept Frontier Sci Adv Environm, Sendai, Miyagi, Japan

[24] Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Sendai, Miyagi, Japan

[25] Chulalongkorn Univ, Dept Microbiol, Translat Res Inflammat & Immunol Res Unit, Bangkok, Thailand

[26] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand

[27] Chulalongkorn Univ, Fac Med, Sch Global Hlth, Dialysis Policy & Practice Program, Bangkok, Thailand

[28] King Chulalongkorn Mem Hosp, Peritoneal Dialysis Excellence Ctr, Bangkok, Thailand

[29] Univ Cologne, Univ Hosp Cologne, Fac Med, Ctr Mol Med Cologne, Cologne, Germany

[30] Univ Cologne, Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Fac Med, Cologne, Germany

[31] German Ctr Infect Res, Cologne, Germany

[32] Nagasaki Univ, Natl Res Ctr Control & Prevent Infect Dis, Nagasaki, Japan

[33] Univ Western Australia, Telethon Kids Inst, Wal Yan Resp Res Ctr, Perth, WA, Australia

[34] Univ Western Australia, Ctr Cell Therapy & Regenerat Med, Med Sch, Perth, WA, Australia

[35] Perth Childrens Hosp, Dept Resp & Sleep Med, Perth, WA, Australia

[36] Curtin Univ, Sch Populat Hlth, Perth, WA, Australia

[37] Kings Coll London, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, Kings British Heart Fdn Ctr Res Excellence, London, England

[38] Kings Coll London, Ageing Res, London, England

[39] Univ Oxford, Dept Physiol Anat & Genet, Med Sci Div, Oxford, England

[40] Univ Auckland, Sch Environm, Auckland, New Zealand

[41] Mae Fah Luang Univ Hosp, Chiang Rai, Thailand

[42] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada

[43] Tokyo Fdn Policy Res, Tokyo, Japan

来源：

LANCET INFECTIOUS DISEASES | 2024年 / 24卷 / 06期

关键词：

D O I：

10.1016/S1473-3099(24)00155-5

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：e348 / e350

页数：3

共 50 条

[21] Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational
Moustsen-Helms, Ida Rask
Bager, Peter
Larsen, Tine Graakjaer
Moller, Frederik Trier
Vestergaard, Lasse Skafte
Rasmussen, Morten
Hansen, Christian Holm
[J]. LANCET INFECTIOUS DISEASES, 2024, 24 (09): : 964 - 973
[22] Report Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses the conserved in ancestral RBD
Liu, Zezhong
Zhou, Jie
Wang, Weijie
Zhang, Guangxu
Xing, Lixiao
Zhang, Keqiang
Wang, Yuanzhou
Xu, Wei
Wang, Qian
Man, Qiuhong
Wang, Qiao
Ying, Tianlei
Zhu, Yun
Jiang, Shibo
Lu, Lu
[J]. CELL REPORTS MEDICINE, 2024, 5 (03)
[23] Computational Modeling of Transformations of Epidemic Waves of BA.2.86/JN.1 SAR-COV-2 Coronavirus Variants on the Basis of Hybrid Oscillators
Perevaryukha, A. Yu.
[J]. TECHNICAL PHYSICS, 2024,
[24] Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Khan, Khadija
Lustig, Gila
Romer, Cornelius
Reedoy, Kajal
Jule, Zesuliwe
Karim, Farina
Ganga, Yashica
Bernstein, Mallory
Baig, Zainab
Jackson, Laurelle
Mahlangu, Boitshoko
Mnguni, Anele
Nzimande, Ayanda
Stock, Nadine
Kekana, Dikeledi
Ntozini, Buhle
van Deventer, Cindy
Marshall, Terry
Manickchund, Nithendra
Gosnell, Bernadett I.
Lessells, Richard J.
Karim, Quarraisha Abdool
Karim, Salim S. Abdool
Moosa, Mahomed-Yunus S.
de Oliveira, Tulio
von Gottberg, Anne
Wolter, Nicole
Neher, Richard A.
Sigal, Alex
[J]. NATURE COMMUNICATIONS, 2023, 14 (01)
[25] Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86
Lasrado, Ninaad
Collier, Ai-ris Y.
Hachmann, Nicole P.
Miller, Jessica
Rowe, Marjorie
Schonberg, Eleanor D.
Rodrigues, Stefanie L.
LaPiana, Austin
Patio, Robert C.
Anand, Trisha
Fisher, Jana
Mazurek, Camille R.
Guan, Ruoran
Wagh, Kshitij
Theiler, James
Korber, Bette T.
Barouch, Dan H.
[J]. VACCINE, 2023, 41 (47) : 6904 - 6909
[26] Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
Qian Wang
Yicheng Guo
Liyuan Liu
Logan T. Schwanz
Zhiteng Li
Manoj S. Nair
Jerren Ho
Richard M. Zhang
Sho Iketani
Jian Yu
Yiming Huang
Yiming Qu
Riccardo Valdez
Adam S. Lauring
Yaoxing Huang
Aubree Gordon
Harris H. Wang
Lihong Liu
David D. Ho
[J]. Nature, 2023, 624 : 639 - 644
[27] First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
Rasmussen, Morten
Moller, Frederik Trier
Gunalan, Vithiagaran
Baig, Sharmin
Bennedbaek, Marc
Christiansen, Lasse Engbo
Cohen, Arieh Sierra
Ellegaard, Kirsten
Fomsgaard, Anders
Franck, Kristina Traeholt
Larsen, Nicolai Balle
Larsen, Tine Graakjaer
Lassauniere, Ria
Polacek, Charlotta
Qvesel, Amanda Gammelby
Sieber, Raphael Niklaus
Rasmussen, Lasse Dam
Stegger, Marc
Spiess, Katja
Tang, Man-Hung Eric
Vestergaard, Lasse Skafte
Andersen, Thomas Emil
Hoegh, Silje Vermedal
Pedersen, Rune Micha
Skov, Marianne Nielsine
Steinke, Kat
Sydenham, Thomas Vognbjerg
Hopp, Morten
Nielsen, Lene
Krause, Tyra Grove
Ullum, Henrik
Jokelainen, Pikka
[J]. EUROSURVEILLANCE, 2023, 28 (36)
[28] JN.1: ongoing considerations of the shifting landscape of SARS-CoV-2 variants
Basu, Soumya
Kayal, Titirsha
Patro, Ponoop Prasad
Patnaik, Amit
[J]. FUTURE MICROBIOLOGY, 2024, 19 (07) : 559 - 562
[29] Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant
Uriu, Keiya
Ito, Jumpei
Kosugi, Yusuke
Tanaka, Yuri L.
Mugita, Yuka
Guo, Ziyi
Hinay Jr, Alfredo A.
Putri, Olivia
Kim, Yoonjin
Shimizu, Ryo
Begum, M. S. T. Monira
Jonathan, Michael
Saito, Akatsuki
Ikeda, Terumasa
Sato, Kei
[J]. LANCET INFECTIOUS DISEASES, 2023, 23 (11): : E460 - E461
[30] SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread
Xinling Wang
Lu Lu
Shibo Jiang
[J]. Signal Transduction and Targeted Therapy, 8

← 1 2 3 4 5 →